The largest database of trusted experimental protocols

Prl sv40 renilla luciferase construct

Manufactured by Promega
Sourced in United States

The PRL-SV40 Renilla luciferase construct is a plasmid that contains the Renilla luciferase gene under the control of the SV40 promoter. Renilla luciferase is a bioluminescent reporter enzyme that can be used to measure gene expression or other cellular processes.

Automatically generated - may contain errors

3 protocols using prl sv40 renilla luciferase construct

1

Cloning and Characterization of Mouse TTP Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genomic sequence of the mouse TTP gene (GenBank accession number NT_187034) was used to engineer PCR cloning primers: 5′-GAGCTCTTCTATCTTTCTGTAACCCAC-3′, 5′-CTCGAGTGGCAGAGAGATCCATGGTGG-3′. Underlined letters are restriction enzyme sites. A 1309-base pair (bp) genomic fragment containing the 5′-flanking region of the TTP gene was isolated by PCR amplification from mouse genomic DNA. Construct pGL3/mTTP p-1309 contains the -1309 bp promoter region of the mouse TTP gene up to nucleotide +48 base pair (i.e., downstream from the mouse TTP mRNA cap site) inserted into the SacI and XhoI sites of the pGL3 basic vector (Promega). A pRL-SV40 Renilla luciferase construct was purchased from Promega (E2231).
RAW264.7 cells were transfected with luciferase reporter constructs using the Neon™ transfection system (Invitrogen). Lysates of the transfected cells were mixed with luciferase assay reagent (Promega), and the chemiluminescent signal was measured in a Wallac Victor 1420 Multilabel Counter (EG&G Wallac, Turku, Finland). Firefly luciferase of pGL3/mTTP p-1309 was normalized to Renilla luciferase of pRL-SV40 in each sample.
+ Open protocol
+ Expand
2

Targeting miR-30a and E2F7 Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
TargetScan (www.targetscan.org/) was used to predict the target gene of miR-30a. To determine the association between miRNA and target genes, PCR was used to amplify the 3′-untranslated region (UTR) of human E2F7, which was then cloned into a pmirGLO vector (Promega Corporation, Madison, WI, USA). The PCR method used is detailed in the previous subsection. Subsequently, Lipofectamine 2000® was utilized to transfect cells in the 24-well plates. The obtained wild type or mutant pmirGLO vector, pRL-SV40 Renilla luciferase construct (5 ng; Promega Corporation) and miR-30a mimic or the respective negative control were co-transfected to each well. After 48 h transfection, cells were extracted and the luciferase activity was determined using the Dual luciferase reporter assay system (DLR® Assay) following 48 h. Firefly luciferase activity in the vectors was normalized to Renilla luciferase activity.
+ Open protocol
+ Expand
3

Shikonin's Transcriptional Regulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were then transfected with 100 ng/well ARE luciferase reporter construct together with 2.5 ng/well pRL-SV40 renilla luciferase construct (Promega) using 2 μL/well LipofectamineTM 2000 (Invitrogen, Grand Island, NY, USA) and allowed to incubate for 24 h, following which the cells were treated with shikonin for 6 h. The cells were then harvested in passive lysis buffer and analyzed using a dual-luciferase reporter assay system on Zenyth multilabel plate reader (Anthos Lab, Heerhugowaard, North Holland, the Netherlands), following the manufacturer’s instructions. Relative light units of the p21 luciferase construct were normalized to those of the Renilla luciferase construct to control for transfection efficiency. Experiments were performed in triplicate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!